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ABSTRACT
 
—Growth factors produced in the uterine endometrium are considered to be involved in the
proliferation of the mouse uterine stromal cells induced by estradiol-17
 
β
 
 (E
 
2
 
) and progesterone (P). The
effect of epidermal growth factor (EGF) and transforming growth factor-
 
α
 
 (TGF-
 
α
 
), one of EGF-related
growth factors, on the proliferation of mouse uterine stromal cells was studied in a serum-free culture. The
growth of the uterine stromal cells was measured by MTT assay. EGF was found to increase the number
of uterine stromal cells in a dose-dependent manner. The DNA-replicating cells were investigated using
the immunocytochemical detection of bromodeoxyuridine (BrdU)-labeled cells. EGF and TGF-
 
α
 
 increased
the percentage of BrdU-labeled cells in a dose-dependent manner. Administration of the combination of
E
 
2
 
 (10
 
–9
 
 M) and P (10
 
–7
 
 M) for 2 days increased the percentage of BrdU-labeled cells 2.3-fold. The stim-
ulatory effect of EGF, TGF-
 
α
 
 and the combination of E
 
2
 
 and P on DNA replication in the uterine stromal
cells was repressed by RG-13022 (10
 
–5
 
 M, the inhibitor of the EGF receptor tyrosine kinase). RT-PCR anal-
ysis of EGF-receptor-, TGF-
 
α
 
-, and EGF-mRNA was carried out in the cultured uterine stromal cells, and
revealed the expression of those mRNAs. These data supported the hypothesis that uterine endometrial
stromal growth induced by sex steroids required the EGF family of ligands such as EGF and TGF-
 
α
 
, both
produced in the stromal cells, acting for DNA synthesis through EGF receptors.
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INTRODUCTION
 
The mammalian uterine endometrium consists of epi-
thelial cells and stromal cells. The proliferation and differen-
tiation of both the uterine endometrial epithelial and stromal
cells are regulated by estrogen and progestin. Estrogen
stimulates the proliferation of luminal and glandular epithe-
lial cells in the uterus, whereas the proliferation of stromal
cells is induced by a combined treatment of estradiol and
progesterone (Huet-Hudson 
 
et al.,
 
 1989). Much evidence
has suggested that the steroid hormone-induced growth of
uterine endometrial cells is mediated by an autocrine or
paracrine action of polypeptide growth factors synthesized
within uterine tissues (Cooke
 
 et al.,
 
 1998). Several reports
have indicated that estrogen-induced proliferation of uterine
epithelial cells is mediated by epidermal growth factor (EGF)
(Iguchi
 
 et al.,
 
 1985; Tomooka
 
 et al.,
 
 1986; Nelson
 
 et al.,
 
1991; Uchima
 
 et al.,
 
 1991; Shiraga
 
 et al.,
 
 2000), while other
reports have shown that transforming growth factor-
 
α
 
 (TGF-
 
α
 
, one of the EGF-related growth factors) (Nelson
 
 et al.,
 
1992), insulin-like growth factor-I (IGF-I) (Murphy
 
 et al.,
 
1987; Shiraga
 
 et al.,
 
 1997) and heparin-binding epidermal
growth factor-like growth factor (HB-EGF) (Zhang
 
 et al.,
 
1994) are implicated in the proliferation of the uterine epithe-
lial cells. As reported above, the regulatory mechanism of
the proliferation of uterine epithelial cells has been exten-
sively studied. However, the molecular mechanism that reg-
ulates the sex steroid hormone-induced proliferation of
uterine stromal cells is not clear.
Immunoreactive EGF has been localized in the neona-
tal and adult mouse uterine stromal cells (Falck and Fors-
berg, 1996). TGF-
 
α
 
 and its mRNA are also detected in both
uterine epithelial cells and stromal cells (Tamada
 
 et al.,
 
1991). Both EGF and TGF-
 
α
 
 are known to bind to EGF
receptors. EGF-receptor mRNA has been detected in the
mouse uterine stromal cells (Das
 
 et al.,
 
 1994; Tong
 
 et al.,
 
1996). These findings imply that EGF and EGF-related
growth factors act on the uterine stromal cells in a paracrine
manner. Therefore, the present study was aimed at clarify-
ing the involvement of EGF and TGF-
 
α
 
 in the estradiol and
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progesterone-induced proliferation of uterine stromal cells,
since in our culture system, treatment with a combination of
estradiol and progesterone stimulated the proliferation of the
mouse uterine stromal cells.
 
MATERIALS AND METHODS
 
Animals
 
Twenty one- to twenty three-day-old female mice of the ICR
strain (CLEA Japan Inc., Osaka, Japan) were used in the present
study. They were housed in a temperature-controlled animal room,
and were given a commercial diet of CA-1 (CLEA Japan Inc.
Osaka, Japan) and tap water 
 
ad libitum
 
. All animal experiments
were performed in accordance with the Guidelines for Animal
Experimentation, Faculty of Science, Okayama University, Japan.
 
Uterine stromal cell isolation
 
Uterine stromal cells were isolated according to the method of
Ross 
 
et al.
 
 (1993). Briefly, uterine horns were removed from the
mice and longitudinally cut to expose the endometrial luminal sur-
face. The tissue fragments were treated with 0.1% trypsin (w/v,
Type III, Sigma Chemical Co., St. Louis, MO, USA) at 4
 
°
 
C for 1 hr,
and then at 37
 
°
 
C for 55 min. Trypsin was inactivated by 0.1% soy-
bean trypsin inhibitor (STI, w/v, Sigma Chemical Co.) at 37
 
°
 
C for 10
min. The epithelial tissues were separated from the stromal tissues
with forceps under a stereoscopic microscope. The endometrial
stromal and myometrial tissues separated from the epithelial tis-
sues were incubated with 0.1% trypsin and 1 mM EDTA at 37
 
°
 
C for
1 hr. Then they were treated with 0.1% STI at 37
 
°
 
C for 10 min. After
gentle pipeting and DNase I (Sigma Chemical Co.) treatment, the
stromal cells separated from the myometrium were collected by
centrifugation. The cell viability was assessed by trypan blue dye
exclusion test and was usually more than 95% in each study. All
chemicals were dissolved in Ca
 
2+
 
- and Mg
 
2+
 
-free Hanks’ solution
containing 20 mM HEPES and 0.3% bovine serum albumin (BSA,
w/v, Fraction V, Sigma Chemical Co.).
 
Uterine stromal cell culture
 
The isolated uterine stromal cells were cultured in a 1:1 mixture
of Dulbecco’s modified Eagle’s medium and Ham’s F12 medium
without phenol red (DME/F12 medium, Sigma Chemical Co.) con-
taining 2% dextran-coated charcoal-treated fetal bovine serum (v/v,
Gibco BRL, Gaithersburg, MD, USA) (DC-FBS) (Lagace
 
 et al.,
 
1980) for 1 day. After a 1-day pre-culture, the cells were cultured in
DME/F12 medium supplemented with BSA (1 g/l), hydrocortisone
(100 
 
µ
 
g/l), triiodothyronine (400 ng/l), transferrin (10 mg/l), glucagon
(10 ng/l), parathormone (200 ng/l), sodium selenite (5 
 
µ
 
g/l) and
insulin (100 
 
µ
 
g/l). Insulin was stocked at a concentration of 10 
 
µ
 
g/
ml in sterile 1% acetic acid solution. E
 
2
 
 (Sigma Chemical Co.), P
(Sigma Chemical Co.) and RG-13022 (BIOMOL Research Labora-
tories, Inc., PA, USA), a specific inhibitor of tyrosine kinase of EGF
receptor (Yoneda
 
 et al.,
 
 1991), were initially dissolved in a small
amount of sterile ethanol. They were all diluted with the culture
medium, and the final ethanol concentrations were less than 0.01%.
Mouse EGF was obtained from Sigma Chemical Co., and human
TGF-
 
α
 
 was obtained from Amersham Pharmacia (Uppsala, Swe-
den).
The isolated uterine stromal cells were seeded in 24-well tissue
culture plates (Becton Dickinson, Lincoln Park, NJ, USA) at a den-
sity of 1–2
 
×
 
10
 
4
 
 cells/ml per well for the determination of the cell
number and the DNA-replicating cells, and in 9-cm tissue culture
plates (Becton Dickinson) at a density of 2
 
×
 
10
 
6
 
 cells per plate for
RNA extraction. The culture was continued at 37
 
°
 
C in humidified
atmosphere of 5% CO
 
2
 
 and 95% air.
 
Immunocytochemical analysis of uterine stromal cells
 
Uterine stromal cells were cultured on a poly-L-lysine-coated
slide glass. The cells were fixed by pre-chilled 100% methanol (–
20
 
°
 
C) for 20 min and dried at room temperature. For vimentin or
cytokeratin detection, the cells were treated with 0.01% trypsin in
0.01 M PBS for 5 min at 37
 
°
 
C, then incubated with mouse anti-
vimentin antibody (Sigma Chemical Co.) or pkk-1 mouse anti-cyto-
keratin antibody (Organon Teknika, NC, USA) overnight at 4
 
°
 
C.
Vimentin-, and cytokeratin-immunoreactivity were visualized using
ABC kit (Vector Laboratories, Burlingame, CA, USA).
 
Determination of the number of uterine stromal cells
 
The number of cultured stromal cells was determined by a
modification of the tetrazolium assay using 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide (MTT, Chemical Co.) as a sub-
strate (MTT assay; Alley
 
 et al.,
 
 1988). The amount of formazan
accumulated after 4-hr incubation at 37
 
°
 
C was spectrophotometri-
cally determined by measuring absorbance at 540 nm and was
used to estimate the number of the cells in a well. The amount of
formazan (the optical density observed at 540 nm) was well corre-
lated with the number of cells in culture (Shiraga
 
 et al.,
 
 1997). The
cell number was expressed as a percentage by regarding the min-
imal cell number as 100%.
 
Determination of the proliferating cells
 
DNA-replicating cells were immunocytochemically detected
using a cell proliferation kit (Amersham Pharmacia). Uterine stromal
cells were seeded on a poly-L-lysine-coated slide glass. Bromode-
oxyuridine (BrdU, 3 mg/ml) was added to the culture medium, and
the culture was continued for 5 hr. About one thousand stromal
cells were observed from each slide. The percentage of BrdU-
labeled cells to total cells was calculated.
 
Primers
 
Primers of EGF receptor, TGF-
 
α
 
 and EGF were designed
based upon the mouse sequence and were obtained from the
Gibco BRL Custom Primers, Life Technologies Asia Pacific (Yoko-
hama, Japan). The primer sequences and the location on the
nucleotide sequences were as follows: EGF receptor 5’ (GTGT-
GAAGAAGTGCCCCCGAAAC, 931–953), EGF receptor 3’ (AAC-
GACCGCCAAAGAAAACTGACC, 1359–1382), TGF-
 
α
 
 5’ (AGCCA-
GAAGAAGCAAGCCATCACT, 367–390), TGF-
 
α
 
 3’ (CTCATTCTC-
GGTGTGGGTTAGCAA, 845–868). EGF 5’(AGATGAGTGTGTGC-
TGGCTAGATC, 2987–3010), and EGF 3’ (TCCGAGTCCTGTAG-
TAGTAAGTCC, 3529–3552).
 
cDNA synthesis and PCR amplification
 
Total RNA (2 
 
µ
 
g) in a final volume of 20 
 
µ
 
l was subjected to
reverse transcription (RT) using Superscript II Reverse Tran-
scriptase (Gibco-BRL) with random primers according to the man-
ufacturer’s instructions. Each PCR was performed using primer
pairs specific for EGF-R, EGF and TGF-
 
α
 
 as described above. PCR
was performed using Takara Taq (Takara Shuzo Co.) and a thermal
cycler (Gene Amp PCR System 9700, Applied Biosystems, Branch-
burg, NJ, USA). The conditions for PCR were as follows: after acti-
vation of DNA polymerase by a 20-sec incubation at 95
 
°
 
C, 35
cycles (for EGF-R cDNA) and 40 cycles (for EGF and TGF-
 
α
 
 cDNA)
of reactions, including denaturation for 30 sec at 95
 
°
 
C and exten-
sion for 1 min at 60
 
°
 
C, followed by an additional extension for 10
min at 60
 
°
 
C. A 10-
 
µ
 
l aliquot of each reaction was electrophoresed
on 2% agarose gel, stained with ethidium bromide, and photo-
graphed under ultraviolet rays.
The size of the resulting DNA fragment following PCR amplifi-
cation was expected to be 452 base pairs (bp) for EGF-R, 502 bp
for TGF-
 
α
 
 and 566 bp for EGF. The cDNA fragments were sub-
cloned into pGEM3zf (+), and sequenced using fluorescent primers
and an automated DNA sequencer.
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Statistics
 
Statistical analysis was carried out by analysis of variance and
Duncan’s multiple range tests.
 
RESULTS
Immunocytochemical analysis of cultured uterine stro-
mal cells
 
Uterine stromal cells were attached to a substratum
within a few hours after seeding. Phase contrast microscopy
revealed that the stromal cells in the culture were flattened,
and were mostly fibroblast-like in appearance (Fig. 1A).
Immunocytochemical study showed that the cultured cells
expressed vimentin (a marker for stromal cells) (Fig. 1B),
but not cytokeratin (a marker for epithelial cells) (Fig. 1C).
These observations indicate that the cultured cells consisted
of uterine endometrial stromal cells.
 
The growth of uterine stromal cells
 
After a 1-day pre-culture in the medium containing 2%
DC-FBS, the uterine stromal cells were cultured in the
serum-free medium. Under the serum-free conditions, the
uterine stromal cells continued to grow until Day 5 in culture,
and the number increased 4.5-fold (Fig. 2).
 
Effect of RG-13022 on the incorporation of BrdU to the
nucleus of uterine stromal cells
 
The nucleus of DNA-replicating stromal cells was
labeled with BrdU, which was detected immunocytochemi-
cally. To examine whether EGF receptor-signaling was
involved in the growth of the uterine stromal cells, the stro-
mal cells were treated with RG-13022, an inhibitor of the
EGF receptor tyrosine kinase, for 2 days, starting on Day 1
 
Fig. 1.
 
Immunocytochemical detection of vimentin and cytokeratin
in the cultured mouse uterine stromal cells. A: Cultured uterine stro-
mal cells are observed by the phase contrast microscope. Bar=50
 
µ
 
m; B: Cultured cells were stained with anti-vimentin antibody.
Bar=20 
 
µ
 
m; C: Cultured cells were stained with anti-cytokeratin anti-
body. Bar=20 
 
µ
 
m; D: Cultured cells were stained without those anti-
bodies as controls. Bar=20 
 
µ
 
m.
 
Fig. 2.
 
A typical example of the growth curve of cultured uterine
stromal cells. After a 1-day pre-culture in DME/F12 medium contain-
ing 2% DC-FBS, the stromal cells were cultured in serum-free DME/
F12 medium. Each point represents the mean (
 
±
 
S.E.M.) of three
independent experiments.
 
Fig. 3.
 
Effect of RG-13022 on the percentage of BrdU-labeled
mouse uterine stromal cells. Stromal cells were treated with RG-
13022 (0, 10
 
–7
 
, 10
 
–6
 
, 10
 
–5 
 
M) for 2 days. RG-13022 treatments were
started on Day 1 in culture. Each column represents the mean
(±S.E.M.) of three independent experiments. 
 
*
 
p<0.05, compared
with control values.
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in culture (Fig. 3). RG-13022 treatment decreased the per-
centage of BrdU-labeled stromal cells in a dose-dependent
manner, and in the following experiments, 10
 
–5
 
 M RG-13022
was used.
 
Effect of EGF on the number and DNA replication of uter-
ine stromal cells
 
Uterine stromal cells were cultured with various concen-
trations of EGF (0.1 to 10 ng/ml) for 6 days. EGF increased
the number of uterine stromal cells in a dose-dependent
manner (Fig. 4). When uterine stromal cells were treated
with EGF (10 ng/ml) from Day 5 in culture, they had
increased 1.3-fold in the number over the control level at
Day 7 in culture. This increase continued, 1.5-fold at Day 9,
and remaining 1.6-fold at Day 11 (Fig. 5). EGF increased
the percentage of BrdU-labeled stromal cells in a dose-
 
Fig. 4.
 
Effect of EGF on the number of the mouse uterine stromal
cells. Stromal cells were treated with EGF (0, 0.1, 1, 10 ng/ml) for 6
days. EGF treatments were started on Day 5 in culture. Each col-
umn represents the mean (
 
±
 
S.E.M.) of three independent experi-
ments. 
 
**
 
p<0.01, compared with control values.
 
Fig. 5.
 
Effect of EGF on the number of mouse uterine stromal cells
in time course. EGF (0, 1, 10 ng/ml) treatments were started on Day
5 in culture. Experiments were replicated independently 3 times.
Each point represents the mean (
 
±
 
S.E.M.)
 
Fig. 6.
 
Effect of EGF on the percentage of BrdU-labeled mouse
uterine stromal cells. Stromal cells were treated with EGF (0, 0.1, 1,
10 ng/ml) for 2 days. EGF treatments were started on Day 5 in cul-
ture. Each column represents the mean (
 
±
 
S.E.M.) of three inde-
pendent experiments. 
 
**
 
p<0.01, compared with control values.
 
Fig. 7.
 
Effect of TGF-
 
α
 
 on the percentage of BrdU-labeled mouse
uterine stromal cells. Stromal cells were treated with TGF-
 
α
 
 (0, 0.1,
1, 10 ng/ml) for 2 days. TGF-
 
α
 
 treatments were started on Day 1 in
culture. Each column represents the mean (
 
±
 
S.E.M.) of three inde-
pendent experiments. 
 
**
 
p< 0.01, compared with control values.
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dependent manner (Fig. 6).
 
Effect of TGF-α
 
 on the DNA replication of uterine stromal
cells
 
Uterine stromal cells were cultured with various
concentrations of TGF-
 
α (0.1 to 10 ng/ml) for 6 days. TGF-
α increased the percentage of BrdU-labeled stromal cells in
a dose-dependent manner (Fig. 7).
Effect of RG-13022 on the DNA replication of uterine
stromal cells induced by exogenous growth factors and
sex steroids
E2 (10–9 M) or P (10–7 M) treatment did not increase the
number of BrdU-labeled cells (data not shown), whereas the
combination of E2 and P significantly increased the number
of BrdU-labeled cells. Similarly, EGF and TGF-α caused the
number of BrdU-labeled cells to increase. To clarify how
EGF receptor signaling is implicated in mediating the action
of E2 and P, the uterine stromal cells were treated with RG-
13022 (10–7 M) in the presence of the combination of E2 and
P. The RG-13022 treatment nullified the E2 and P-induced
DNA replication of the uterine stromal cells as well as the
EGF- or TGF-α-induced DNA-replication (Fig. 8).
Detection of EGF-receptor-, TGF-α-, and EGF-mRNAs in
cultured uterine stromal cells
RT-PCR was performed to evaluate EGF receptor-,
TGF-α-, and EGF-mRNA expression in the cultured uterine
stromal cells using primer pairs for the amplification of EGF
receptor cDNA (Fig. 9, lane 1), TGF-α cDNA (Fig. 9, lane 3)
and EGF cDNA (Fig. 9, lane 5). These amplifications
resulted in single bands in the ethidium bromide-stained
gels. From the size of the RT-PCR products, it was con-
cluded that the 452-bp product, 502-bp product and 566-bp
product were amplified cDNAs of EGF receptors, TGF-α,
and EGF, respectively. The sequencing analysis revealed
that the amplified cDNA fragments were cDNAs coding
parts of the mouse EGF receptor, TGF-α and EGF, respec-
tively (data not shown). To exclude the possibility of
genomic contamination, RNA samples were amplified by
PCR without RT, and no PCR products were found (Fig. 9,
lanes 2, 4 and 6).
DISCUSSION
The uterine stromal cells continued to grow under the
serum-free condition. RG-13022 treatment inhibited the pro-
liferation of the uterine stromal cells even in the absence of
EGF and TGF-α under serum-free conditions, which sug-
gests the involvement of EGF-receptor signaling in the
growth of uterine stromal cells. In addition, we demonstrated
the synthesis of EGF and TGF-α in the uterine stromal cells
and their stimulatory effect on DNA replication of uterine
stromal cells. From these findings, we concluded that
endogenous EGF-related growth factors were involved in
the regulatory mechanism of the growth of mouse uterine
stromal cells.
In our culture system, the uterine stromal cells ceased
to increase in number on Day 5 in culture. However, when
the medium was treated with EGF beginning on Day 5, the
uterine stromal cells started to increase in number, indicat-
Fig. 8. Effect of the association of RG-13022 and sex steroid hor-
mones, growth factors on the percentage of BrdU-labeled mouse
uterine stromal cells. Stromal cells were treated with E2 (10–9 M)
and P (10–7), EGF (10 ng/ml), TGF-α (10 ng/ml) in the absence of
10–5 M RG-13022 (open columns) or the presence (hatched col-
umns) for 2 days. All treatments were started on Day 1 in culture.
Each column represents the mean (±S.E.M.) of three independent
experiments. **p<0.01, compared with control values. ##p< 0.01,
compared with vehicle-treated groups.
Fig. 9. Electrophoretic analysis of RT-PCR products. One µg of
total RNA extracted from cultured uterine stromal cells was reverse-
transcribed and amplified by PCR using primers for the amplification
of EGF receptor (lane 1), TGF-α (lane 3) and EGF (lane 5) as
described in Materials and Methods. For negative control, RNA
samples (without RT) were amplified using primers for EGF receptor
(lane 2), TGF-α (lane 4) and EGF (lane 6). The one-tenth aliquot of
each reaction was electrophoresed, and stained with ethidium bro-
mide. The sizes of the RT-PCR products were determined by com-
parison with 100 bp DNA Ladder as markers. TGF-α-, EGF- and
EGF-receptor-amplified cDNA bands were 502, 566 and 452 bp,
respectively. L: 100-bp ladder.
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ing that the cessation of the growth of uterine stromal cells
was partly due to the depletion of endogenous growth fac-
tors, probably EGF-related growth factors.
In the adult ovariectomized mouse uterus, the prolifera-
tion of stromal cells is induced by a combination of E2 and
P (Huet-Hudson et al., 1989). In the present study treatment
with E2 or P failed to stimulate DNA replication in the uterine
stromal cells, whereas the combination of E2 and P stimu-
lated DNA replication in vitro. The proliferation of the uterine
stromal cells induced by the combination of E2 and P in a
serum-free culture is quite consistent with the proliferation of
uterine stromal cells induced by E2 and P in vivo.
The DNA replication that had been enhanced by the
combined treatment with E2 and P was nullified by an
RG-13022 treatment. This finding suggests that the action
of E2 and P on the DNA replication of uterine stromal cells
requires the EGF-receptor signaling. Therefore, EGF-related
growth factors are considered to mediate the action of the
combination of E2 and P through the EGF receptor. This
hypothesis is supported by a previous report that in
response to estrogen treatment DNA synthesis in uterine
endometrial stromal cells of EGF-receptor knockout mice is
depressed compared with that of wild type mice, suggesting
that EGF-receptor signaling is required in estrogen-induced
proliferation of uterine endometrial stromal cells (Hom et al.,
1998).
EGF and EGF mRNA levels are increased by estrogen
in the mouse uterus (DiAugustine et al., 1988; Falck and
Forsberg, 1996). The TGF-α mRNA level is also increased
by estrogen in the adult ovariectomized rat uterus (Borgun-
dvaag et al., 1992) and in the immature mouse uterus (Nel-
son et al., 1992). Immunoreactive TGF-α protein is secreted
at high levels into the mouse uterine luminal fluid after estro-
gen treatment (Nelson et al., 1992). As mentioned above in
vivo analysis of EGF and TGF-α expression in the uterus
has been well reported. However, physiological growth
factors which are involved in steroid hormone-induced pro-
liferation of the stromal cells remains to be determined.
Interestingly, in a study of pituitary growth, we found that
TGF-α is a mediator of estrogen-induced proliferation of
mammotrophs, since treatment of mouse pituitary cells with
antisense TGF-α oligodeoxynucleotide or anti-TGF-α anti-
bodies inhibited estrogen-induced proliferation of mam-
motrophs (Oomizu et al., 2000; Takahashi et al., 2002;
Sharma et al., 2003). These results altogether suggest that
estrogen-induced growth of various tissues is controlled by
a common mechanism of an autocrine or paracrine action of
growth factors.
The stromal cells do not proliferate when progesterone
receptor antagonists are used to block the receptor function
(Cullingford and Pollard, 1988; Rider and Psychoyos, 1994)
or when anti-progesterone antibodies are administered dur-
ing early pregnancy (Rider et al., 1986). Progesterone is
essential for the growth of uterine stromal cells. The
increase in the progesterone receptor level is evoked by
estrogen (Aronica and Katzenellenbogen, 1991). The mech-
anism of cooperative action between E2 and P needs to be
clarified.
In conclusion, we found that estradiol and progesterone
co-operatively stimulated the proliferation of uterine stromal
cells, and that EGF-receptor ligands were involved in the
steroid-induced growth of uterine endometrial stromal cells.
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